CPTA HOE 140Alternative Names: Tc 99m CPTA-icatibant conjugate; Tc 99m icatibant-CPTA conjugate
Latest Information Update: 16 Nov 1998
At a glance
- Originator Aventis
- Class Radiopharmaceutical diagnostics
- Mechanism of Action Radionuclide imaging enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 16 Nov 1998 No Development Reported - Preclinical development for Rheumatoid arthritis (diagnosis) in Germany (IV)
- 26 Nov 1996 Preclinical development for Rheumatoid arthritis (diagnosis) in Germany (IV)